SEC Tracker
Get the app

Medline MDLN

Medline reports $318 million net income for Q3 2026

Form
10-Q
Filed
Importance
Notable
  1. Revenue of $7.86 billion for the three months ended Sep 26, 2026
  2. Net income of $318 million for the three months ended Sep 26, 2026
  3. Diluted EPS of $0.22 for the three months ended Sep 26, 2026
  4. Cash and equivalents of $2.32 billion as of Sep 26, 2026

Written from the 10-Q on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Medline files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Solventum SOLV public float $13.1B, Jun 30, 2025
  2. Hologic HOLX public float $13.6B, Mar 29, 2025, over 18 months old
  3. Align Technology ALGN public float $11.1B, Jun 30, 2025
  4. West Pharmaceutical Services WST public float $15.7B, Jun 30, 2025
  5. Baxter International BAX public float $16.0B, Jun 30, 2025